#Opioids

New Medicaid Policy Will Help States Better Fight the Opioid Crisis

A $6.6 million grant aims to integrate services for HIV, hepatitis B and C and substance misuse into primary care clinics across the state.

Data from a new study by the National Institutes of Health was published in the American Journal of Public Health.

National Institutes of Health’s Helping to End Addiction Long-term Initiative is finding scientific solutions to address the opioid crisis.

Mobile clinics could be innovative strategy for expanding access to care and providing uninterrupted treatment for people who inject drugs.

This California county had the highest hepatitis C rates in the state, and yet officials have hampered syringe programs.

The death rate spiked right after the COVID-19 pandemic began.

Areas with lower population density have not seen the same slowdown as urban areas.

Researchers found that longer usage of injection drugs was positively linked to hep C testing.

The Centers for Disease Control and Prevention has learned difficult lessons from such outbreaks over the past five years.

People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.

As overdose death rates have risen in this population, life expectancy has increasingly narrowed.

Infective endocarditis is a life-threatening bacterial infection of the heart valves that is associated with injection drug use.

This is one of many ways that people who use drugs can engage in harm reduction during the coronavirus pandemic.

A national survey found that primary care physicians had little interest in prescribing buprenorphine or naltrexone.

Even after federal regulators relaxed rules requiring daily clinic visits, these bad actors are still bringing patients in for monitoring.

The coronavirus pandemic has upended the usual systems governing the dispensation of medication-assisted treatment.